Vitalant is a 501(c)(3) organization based in Scottsdale, Arizona, registered in 2015, with $739,592,382 in FY2024 revenue. CharityIndex grades it A, and it directs about 86% of spending to programs.
Revenue (FY2024)
$739.6M
▲ 7.8% vs prior year
Health median: $840K
Expenses (FY2024)
$738.9M
Net assets
$655.5M
Employees
5,069
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Vitalant: 86% to programs · $0 to raise $100 earns a A on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Vitalant: 11 mo reserves · +0% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Vitalant: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Vitalant: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Unite blood and biologics donors, talent, and innovation to save and improve lives.
Vitalant laboratories (vl) - vitalant laboratories' staff of highly trained and experienced personnel provide support and expertise to hospitals, transfusion and transplant centers and other healthcare facilities for their transfusion medicine needs. vl operates eighteen laboratories for (irl) immunohematology reference lab, three (hla) histocompatibility laboratories and four (ctl) cellular therapy laboratories. together they solve some of the most complex immunohematologic compatibility cases and ensure life-saving blood and cellular therapy services to hospitals all across the united states. for healthcare facilities in multiple states, vl also serves as a blood bank, providing complete transfusion services including patient compatibility testing and delivery.
Vitalant research institute (vri) - the vitalant research institute carries out studies funded by extramural grants (nih and other agencies) and receives intramural funding from vitalant between $7.0m and $10.0m each year. vri has historically been noted for contributions to infectious disease testing / monitoring, epidemiology / public policy, and selected non-infectious risks of transfusion. recent research efforts include characterization of metabolic and genetic factors that influence red blood cell stability, and since the pandemic, a host of critically important studies to understand sars-cov-2 epidemiology, the safety of the blood supply, the time course of its antibody response/immunity and the efficacy of covid convalescent plasma. a public service, vri's research extends far beyond organizational development efforts, benefiting patients all over the us (and the world) as well as competing us blood centers, improving blood product quality, recipient safety, and the donor experience. vri supports training programs for specialists in transfusion medicine and the development of research scientists in a host of transfusion medicine subspecialties. vri investigators published more than 100 peer-reviewed original research papers in 2024 along with many more reviews, editorials, book chapters and scientific meeting abstracts. together, vri's 12 investigators, 2 clinical investigators, 16 affiliated investigators, 6 core leaders, 10 administrative staff and ~70 scientists, technologists and post-docs have contributed to major discoveries in transfusion safety and efficacy.
Revenue grew from $502.7M (FY2013) to $739.6M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
0.1%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$891.0M
Total liabilities
$235.6M
Net assets
$655.5M
Salaries & benefits
$416.2M
56% of expenses
Board members
14
14 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $739,592,382▲7.8% | $738,892,381▲2.2% | $655,490,622▲8.8% | $891,045,288▲7.3% | 990 |
| 2023 | $686,191,950▼1.9% | $723,148,230▲4.9% | $602,694,787▲4.8% | $830,626,770▲2.5% | 990 |
| 2022 | $699,399,272▼16.4% | $689,126,228▲1.3% | $575,129,435▲2.1% | $810,635,110▲5.9% | 990 |
| 2021 | $836,631,426▲28.4% | $680,159,506▲7.8% | $563,144,792▲73.3% | $765,654,359▲35.5% | 990 |
| 2020 | $651,670,836▲23.7% | $630,785,279▲16.3% | $325,009,556▲20.1% | $564,968,755▲26.1% | 990 |
| 2019 | $526,624,616▼1.2% | $542,313,136▼0.9% | $270,606,879▼9.9% | $448,018,347▼8.1% | 990 |
| 2018 | $532,834,898▲11.3% | $547,454,598▲0.9% | $300,238,300▼6.9% | $487,696,681▼16.0% | 990 |
| 2017 | $478,935,219▼29.8% | $542,500,593▼23.5% | $322,332,090▲63.9% | $580,483,291▲38.9% | 990 |
| 2016 | $682,444,156▲6.6% | $708,806,186▲16.4% | $196,672,819▲3.2% | $417,999,357▲9.3% | 990 |
| 2015 | $639,900,462▲27.4% | $609,128,412▲15.4% | $190,494,322▼5.5% | $382,520,351▼4.8% | 990 |
| 2014 | $502,094,175▼0.1% | $527,890,475▲4.6% | $201,515,017▼23.7% | $401,630,955▼0.4% | 990 |
| 2013 | $502,726,282 | $504,840,689▲3.2% | $264,170,299▲23.0% | $403,325,178▲11.2% | 990 |
| 2012 | — | $489,013,853▼0.1% | $214,760,381▲11.1% | $362,750,888▲5.7% | 990 |
| 2011 | — | $489,664,466▲2.0% | $193,266,543▼4.2% | $343,197,402▲0.1% | 990 |
| 2010 | — | $480,024,770 | $201,729,003 | $342,692,417 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: David Green — $1,752,599 (0.24% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| David Green | President/ceo | 55 | $1,752,599 |
| Robert Van Tuyle | Evp, Chief Operations Officer | 55 | $870,577 |
| Ralph Vassallo Md | Evp, Chief Medical & Scientific Officer | 54 | $760,485 |
| Bhavi Shah | Evp, Clo, General Counsel, Secretary | 40 | $731,723 |
| Maureen Musselman | Evp, Chief Financial Officer, Treasurer | 40 | $705,819 |
| Mary Beth Bassett | Evp, Chief Quality Officer | 55 | $661,204 |
| Anthony Bobos | Evp, Chief Information Officer | 55 | $660,057 |
| Roxanne Tata | Vp, Quality Systems & Reg Services | 45 | $659,179 |
| Brian Custer | Svp, Research & Scientific Programs | 45 | $608,577 |
| Peter Michaelson | Former Evp, Chief People Officer | 0 | $598,726 |
| Michael Busch Md | Vp, Research & Scientific Programs | 45 | $587,939 |
| Clifford Numark | Svp, Chief Strat Mkt Donor Svc | 45 | $570,589 |
| Kevin Land | Vp, Clinical Services | 45 | $565,499 |
| Dirk Johnson | Evp, Blood Ops & Chief of Staff | 55 | $553,578 |
| Manny Ocasio | Evp, Chief People Officer | 55 | $285,340 |
| Bill Gates | Trustee/chair | 4 | $43,250 |
| Patricia Abrego-santucci | Trustee | 2 | $43,250 |
| Robert S Cole | Trustee | 2 | $43,250 |
| James T Schraith | Trustee | 2 | $41,500 |
| Sunny P Chico | Trustee | 2 | $40,750 |
| Contractor | Services | Paid |
|---|---|---|
| Creative Testing Solutions | Laboratory Testing | $45,418,179 |
| Ups | Delivery Services | $5,085,213 |
| Mak Systems Corporation | Technology Services | $3,884,594 |
| Upmc | Physician Services | $3,247,621 |
| One Lambda | Laboratory Testing | $2,407,402 |
61 grants to Vitalant totaling $21.3M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Colorado Gives Foundation | Program support | 2024 | $2,210,186 |
| Kaiser Foundation Hospitals | Research / project support | 2024 | $29,030 |
| American Online Giving Foundation Inc | General support | 2024 | $15,370 |
| Colorado Gives Foundation | General purpose | 2023 | $2,484,362 |
| Kaiser Foundation Hospitals | Research / project support | 2023 | $131,830 |
| Scripps Research Institute | Grants for scientific research | 2023 | $131,502 |
| Cornell University | Research | 2023 | $71,218 |
| Emory University | Research/subcontract | 2023 | $31,833 |
| American Online Giving Foundation Inc | General support | 2023 | $17,886 |
| Colorado Gives Foundation | General purpose | 2022 | $4,518,592 |
| University of Pittsburgh | Research- subcontract | 2022 | $345,253 |
| Fred Hutchinson Cancer Center | Vaccine and infectious disease research | 2022 | $95,624 |
| Arizona Community Foundation | General support | 2022 | $90,700 |
| Cornell University | Research | 2022 | $79,150 |
| Kaiser Foundation Hospitals | Research / project support | 2022 | $50,428 |
8 grants totaling $1.7M in FY2024. All grants made by Vitalant →
| Recipient | Purpose | Amount |
|---|---|---|
| University of Pittsburgh | Establish hemostasis clinic | $1,500,000 |
| American Association of Blood Banks | Nfb/cord support | $75,000 |
| Unm Foundation | Fellowship support | $41,790 |
| Flights For Life Inc | Donation | $25,000 |
| Blood Center Foundation of the Inland Northwest | Donation | $16,809 |
| Foothills Food Bank | Donation | $10,000 |
| The Community Service Education and Research Fund Cserf of the | Donation | $9,422 |
| Hackensack Meridian Health Inc | Donation | $8,000 |
Explore more
Data for Vitalant (EIN 86-0098929) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.